[Federal Register Volume 67, Number 69 (Wednesday, April 10, 2002)]
[Notices]
[Pages 17470-17471]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-8660]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 5, 2001, and published in the Federal 
Register on October 17, 2001, (66 FR 52782), Wildlife Laboratories, 
Inc., 1401 Duff Drive, Suite 600, Fort Collins, Colorado 80524, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of carfentanil (9743), a basic 
class of controlled substance listed in Schedule II.
    The firm plans to manufacture the listed controlled substance for 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Wildlife Laboratories to 
manufacture carfentanil is consistent with the public interest at this 
time. DEA has investigated Wildlife Laboratories to ensure that the 
company's registration is consistent with the public interest. This 
investigation included inspection and testing of the company's physical 
security systems, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.


[[Page 17471]]


    Dated: March 27, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-8660 Filed 4-9-02; 8:45 am]
BILLING CODE 4410-09-M